Infection and preterm birth

W W Andrews1, J C Hauth, R L Goldenberg

  • 1Department of Obstetrics & Gynecology and The Center for Research in Women's Health, University of Alabama at Birmingham, 35249-7333, USA.

Insights

Genital tract infections are linked to spontaneous preterm birth, a major cause of infant mortality and handicap. Antibiotic trials show promise but require further research for effective prevention strategies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Diseases

Background:

  • Preterm birth affects 11% of US pregnancies, leading to infant mortality and long-term neurological handicap, particularly in infants born before 32 weeks' gestation.
  • Despite improved survival rates for preterm infants, long-term handicap rates remain unchanged, and preterm birth rates are increasing.
  • Clinically silent upper genital tract infections are implicated in the pathophysiology of spontaneous preterm births, especially early-term births.

Purpose of the Study:

  • To review the current understanding of the relationship between genital tract microbial infections and spontaneous preterm birth.
  • To evaluate the availability and utility of markers for identifying women with genital tract infections.
  • To analyze the results of recent randomized clinical trials of antibiotic therapy for preterm birth prevention.

Main Methods:

  • Review of current literature on genital tract infections and preterm birth.
  • Assessment of diagnostic markers for genital tract infections.
  • Analysis of prospective randomized clinical trials evaluating antibiotic therapy.

Main Results:

  • Genital tract infections are a significant factor in spontaneous preterm birth.
  • Diagnostic markers for these infections have varying degrees of usefulness.
  • Antibiotic therapy trials have yielded mixed results, with specific strengths and limitations.

Conclusions:

  • Further research is needed to refine diagnostic markers and optimize antibiotic treatment strategies.
  • Clinical management strategies require careful consideration of trial evidence and future research directions.
  • Understanding the role of genital tract infections is crucial for reducing preterm birth and associated handicaps.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...